Tex. Health & Safety Code § 441.0101 · Subchapter C. ENFORCEMENT
RIGHT TO CORRECT.
Text — Current through the 89th 2nd Called Legislative Session, 2025
(a) If the department determines that a pharmaceutical drug manufacturer failed to submit a report or fee required under, or failed to submit the report or fee in the manner prescribed by, Subchapter B and the rules adopted under this chapter, the department shall provide written notice of the failure to the manufacturer.
(b) On receipt of notice described by Subsection (a), a pharmaceutical drug manufacturer shall submit, as applicable:
(1) a report that:
(A) complies with Subchapter B and rules adopted under this chapter; and
(B) addresses the issues raised in the notice; or
(2) the fee required by Section 441.0055.
(c) The department may not assess an administrative penalty under Section 441.0102 against a pharmaceutical drug manufacturer that submits to the department the required report or fee, as applicable, on or before the 45th day after the date the manufacturer receives notice under Subsection (a).
Notes and commentary — not statutory text
History
Added by Acts 2021, 87th Leg., R.S., Ch. 50 (H.B. 1033), Sec. 5, eff. September 1, 2021.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/HS/htm/HS.441.htm
- Text hash
- sha256 6244197609ddae364729e56d00330f87c014a11e833943da1221028fbe82e2ce
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
This section cites
Provisions in this library that the text above cites, as it prints each citation. A range cited as “ss. 61.13-61.16” links its first and last provisions.
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.